Despite a historic downturn in employment, stocks managed to climb higher last week as investors were emboldened by the pace of economic re-openings, both here and abroad. Click here to read the full article.

Stock prices ended the week slightly lower, despite news of positive results from a test trial of a COVID-19 drug treatment and several states easing their economic lockdowns. Click here to read the full article.

Stock prices bounced around last week as investors reacted to wild swings in the price of oil and reports that called into question the efficacy of two potential virus treatments. Click here to read the full article.

Stock prices pushed higher last week as news of a White House plan to reopen the economy and reports of a potential COVID-19 treatment helped the market overcome weak economic data and an ugly start to the corporate earnings season. Click here to read the full article.

The stock market staged a broad rally last week, buoyed by the prospect that COVID-19’s grip on the nation might be easing and news of another Federal Reserve program to help stabilize businesses. Click here to read the full article.

As I’m sure you know, the $2 trillion “Coronavirus Aid, Relief, and Economic Security” (“CARES”) Act was recently signed into law. The CARES Act is designed to help those most impacted by the COVID-19 pandemic, while also providing key provisions that may benefit retirees.[1] To put this monumental legislation in perspective, Congress earmarked $800 billion […]